Atorvia

Atorvia is a pre-clinical stage biotechnology company focused on translating biological insight into transformative medicines for organ failure and chronic diseases. By bridging molecular understanding with clinical translation, Atorvia accelerates the development of novel therapeutics designed to restore organ health and improve patient outcomes. Headquartered in Ontario, Canada, Atorvia is on a mission to rapidly advance novel, proprietary therapeutics to tackle currently untreatable diseases, starting in kidney.